Pharma Focus Asia
KP - Sustainable Packaging Solutions

Eli Lilly to upgrade Brazil production site with 15 million real ($6.4 million)

Introduction:

US pharma major Eli Lilly's subsidiary in Brazil invests 15 million real (US$6.4 million) over the next two years to renew the packaging plant located in Sao Paulo, Brazil.

Expansion Strategy:
The site currently makes 10 million packages a year. The investment is set to boost production and improve quality addressing the local demand genearated by growing middle class.

Features:
2 of the 4 blister pack machines to be replaced with state of the art technology, optimising layout and improving control systems in other production lines.

The facility currently produces and packs Cialis, Evista, Prozac, Zyprexa. It also packages Cymbalta, Alimta, Gemzar.

The investment will allow the unit to design and pack the drugs Livalo and complete manufacturing Cialis Daily starting next year.

Budget:
An estimated 15 million real ($6.4 million) will be spent during 2014-16 for upgrading the manufacturing facility.

Specifications Table:

  • Company Name
  • Eli Lilly
  • Location
  • Sco Paulo, Brazil
  • Estimated investment
  • 15 million real (USD 6.4 million)
  • Expansion Type
  • Technology Upgradation
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelTFS - ODW - The Technology Debate: Single-Use vs. Stainless SteelAsia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 20244th Middle East Pharmacoeconomics and Drug Policy Summit 2024Digital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference
Searching for an end-to-end patient tech solution?